Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50–64 years old in the United States
- Resource Type
- Article
- Source
- In
Vaccine 4 January 2023 41(1):49-60 - Subject
- Language
- ISSN
- 0264-410X